anmelden
OMX Copenhagen PI
1.287,77
PKT
+2,24
PKT
+0,17
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Copenhagen PI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 12.04.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 11.04.18 | Novo Nordisk market-perform | Bernstein Research | |
| 27.03.18 | Novo Nordisk buy | UBS AG | |
| 19.03.18 | Novo Nordisk market-perform | Bernstein Research | |
| 08.03.18 | Novo Nordisk Underweight | Barclays Capital | |
| 05.03.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 26.02.18 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 23.02.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 23.02.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 22.02.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.02.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 20.02.18 | Novo Nordisk Hold | Kepler Cheuvreux | |
| 19.02.18 | Novo Nordisk buy | UBS AG | |
| 14.02.18 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.02.18 | Novo Nordisk buy | UBS AG | |
| 06.02.18 | Novo Nordisk Hold | S&P Capital IQ | |
| 02.02.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 02.02.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 02.02.18 | Novo Nordisk buy | UBS AG | |
| 02.02.18 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 02.02.18 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 01.02.18 | Novo Nordisk buy | UBS AG | |
| 26.01.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 26.01.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 22.01.18 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.01.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 19.01.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.01.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 16.01.18 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 16.01.18 | Novo Nordisk market-perform | Bernstein Research | |
| 15.01.18 | Novo Nordisk buy | UBS AG | |
| 12.01.18 | Novo Nordisk buy | UBS AG | |
| 09.01.18 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 09.01.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 08.01.18 | Novo Nordisk buy | UBS AG | |
| 29.12.17 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 15.12.17 | Novo Nordisk Verkaufen | DZ BANK | |
| 12.12.17 | Novo Nordisk buy | UBS AG | |
| 07.12.17 | Novo Nordisk Reduce | HSBC | |
| 06.12.17 | Novo Nordisk overweight | Morgan Stanley |